Skip to main content
. 2014 Oct 1;8(6):2616–2620. doi: 10.3892/ol.2014.2582

Figure 2.

Figure 2

Immunohistochemical analysis of ADAM17 immunoreactivity in normal brain and glioma tissues (magnification, ×400). Gliomas with high grades exhibited stronger ADAM17 protein expression compared with gliomas with lower grades and the normal brain tissues (P<0.05). ADAM17, a disintegrin and metalloproteinase-17.